{"id":"https://openalex.org/W2767326703","doi":null,"title":"Resistance to programmed death protein 1 blockade mediated by somatic JAK1/2 mutations","display_name":"Resistance to programmed death protein 1 blockade mediated by somatic JAK1/2 mutations","alternate_titles":[],"publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W2767326703","mag":"2767326703"},"language":"en","primary_location":{"id":"pmh:oai:escholarship.org/ark:/13030/qt9v23j2p9","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/9v23j2p9","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"etd"},"parent_works":[],"lineage":["https://openalex.org/W2767326703"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067826298","display_name":"Daniel Sanghoon Shin","orcid":"https://orcid.org/0000-0002-3784-5336","observed_orcids":["https://orcid.org/0000-0002-3784-5336"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Daniel Sanghoon Shin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3784-5336","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5067826298"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9179999828338623},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.6159999966621399},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.800000011920929},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9070000052452087},{"id":"https://openalex.org/keywords/interferon-gamma-signaling","display_name":"interferon-gamma signaling","score":0.9570000171661377},{"id":"https://openalex.org/keywords/interferon-gamma-receptor","display_name":"interferon-gamma receptor","score":0.8569999933242798},{"id":"https://openalex.org/keywords/irf-1","display_name":"IRF1","score":0.9679999947547913},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.6439999938011169},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6362906694412231},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6186720132827759},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5910758972167969},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.48460397124290466},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.476857990026474},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47321954369544983},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43953636288642883},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.4195515811443329},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.353353887796402},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2942603528499603},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2593727111816406}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:escholarship.org/ark:/13030/qt9v23j2p9","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/9v23j2p9","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"etd"},{"id":"pmh:qt9v23j2p9","doi":null,"is_oa":false,"landing_page_url":"http://www.escholarship.org/uc/item/9v23j2p9","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Shin, Daniel Sanghoon. (2017). Resistance to programmed death protein 1 blockade mediated by somatic JAK1/2 mutations. UCLA: Molec, Cell, &amp; Integ Physiology 0568. Retrieved from: http://www.escholarship.org/uc/item/9v23j2p9","raw_type":"dissertation"},{"id":"mag:2767326703","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/content/qt9v23j2p9/qt9v23j2p9.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2557336488","https://openalex.org/W2592409680","https://openalex.org/W2734739695","https://openalex.org/W2465860350","https://openalex.org/W7010606000","https://openalex.org/W2112523832","https://openalex.org/W2947037851","https://openalex.org/W2622991812","https://openalex.org/W2779008743","https://openalex.org/W2539229861"],"abstract_inverted_index":{"Blocking":[0],"programmed":[1,108],"death":[2,109],"protein":[3,110],"1":[4,112,134,142],"(PD-1)":[5],"negative":[6],"immune":[7],"receptor":[8,182],"has":[9],"produced":[10],"remarkable":[11],"progress":[12],"in":[13,104,130,141,188,193,220],"treating":[14],"patients":[15,48,58,81,96,121,137,145],"with":[16,39,91,97,122,138,146,153,228,233],"advanced":[17,98],"cancers,":[18],"such":[19],"as":[20],"melanoma,":[21,99],"lung,":[22],"head":[23],"and":[24,36,54,78,140,197,213,256],"neck,":[25],"kidney,":[26],"bladder,":[27],"Hodgkin\u2019s":[28],"disease,":[29],"mismatch":[30,147],"repair":[31,148],"deficient":[32,149],"colon":[33,150],"cancer,":[34],"liver":[35],"ovarian":[37],"cancer":[38,151],"high":[40],"mutational":[41],"burden,":[42],"etc.":[43],"However,":[44],"only":[45],"subset":[46],"of":[47,57,106,133,135,143,158,170,250,252],"are":[49,215,246],"benefitting":[50],"from":[51],"this":[52,117],"therapy":[53],"substantial":[55],"portion":[56],"have":[59,87],"relapsed":[60],"after":[61],"long":[62],"durable":[63],"response.":[64],"Therefore,":[65,239],"it":[66],"is":[67],"critical":[68],"to":[69,74,168,236,258,262,267],"understand":[70],"its":[71],"resistance":[72,93,266],"mechanisms":[73],"improve":[75],"therapeutic":[76],"efficacy":[77],"select":[79],"right":[80],"for":[82,205,225],"checkpoint":[83],"blockade":[84,269],"immunotherapy.":[85],"We":[86,114],"identified":[88],"mutations":[89,127,166,245],"associated":[90,232],"acquired":[92,265],"among":[94,120],"4":[95],"including":[100],"JAK1/2":[101,125,165,185,243],"that":[102,116,242],"resulted":[103],"loss":[105,169],"adaptive":[107],"ligand":[111],"(PD-L1).":[113],"reasoned":[115],"could":[118],"occur":[119],"primary":[123,263],"resistance.":[124],"inactivating":[126],"were":[128,231],"found":[129],"tumor":[131],"biopsies":[132],"23":[136],"melanoma":[139,161,207],"16":[144],"treated":[152],"PD-1":[154,237,268],"blockade.":[155,238],"Two":[156],"out":[157],"48":[159],"human":[160],"cell":[162,208],"lines":[163,209],"had":[164],"led":[167],"PD-L1":[171,221,254],"expression":[172,255],"upon":[173],"interferon":[174,180,202,259],"gamma":[175,181],"exposure":[176],"mediated":[177],"by":[178],"disabled":[179],"signaling":[183,203],"pathway.":[184],"loss-of-function":[186,244],"alterations":[187],"TCGA":[189],"confer":[190],"adverse":[191],"outcomes":[192],"patients.":[194],"sh-RNA":[195],"screening":[196],"chromatin":[198],"immunoprecipitation":[199],"approach":[200],"on":[201],"genes":[204,230],"selected":[206],"revealed":[210],"JAK1/2,":[211],"STAT1/2/3":[212],"IRF-1":[214],"the":[216],"key":[217],"molecules":[218],"involved":[219],"expression.":[222],"RNA-seq":[223],"analyses":[224],"tumors":[226],"enriched":[227],"these":[229],"clinical":[234],"response":[235,257],"we":[240],"propose":[241],"a":[247],"genetic":[248],"mechanism":[249],"lack":[251],"reactive":[253],"gamma,":[260],"leading":[261],"or":[264],"therapy.":[270]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2767326703","counts_by_year":[],"updated_date":"2026-08-26T07:47:46.906454","created_date":"2017-11-17T00:00:00"}
